Millions still lack access to life-saving medicines, not because science failed, but because patents, prices, and politics get in the way. This deep dive unpacks how countries have used (and sometimes avoided) TRIPS flexibilities over the past 25 years to break monopolies, enable generics, and respond to crises from HIV to COVID-19 and cancer. With ...
A recent chapter titled “The Current Situation of Medicines Quality in Low- and Middle-Income Countries: New Challenges to be Addressed” (IntechOpen, 2025) sheds light on a growing global health concern: 10.5% of medicines worldwide are of poor quality, with the greatest impact seen in low- and middle-income countries. Harsh climates, weak regulatory systems, and fragmented supply ...
Ethiopia has reached a major milestone in medicines regulation, achieving WHO Maturity Level 3 (ML3)! This recognition highlights the Ethiopian Food and Drug Authority’s commitment to ensuring that medicines and vaccines meet international standards of quality, safety, and efficacy. Ethiopia now joins eight other African countries in demonstrating strong, well-functioning regulatory systems that protect public ...
The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends, On 14 May, the WHO released the document “WHO guideline on balanced national controlled medicines policies to ensure medical access and safety: rapid communication” – accessible at https://iris.who.int/bitstream/handle/10665/381452/B09419-eng.pdf?sequence=1 The purpose is ‘to assist WHO Member States ...
A new study highlights the challenges of accessing essential medicines in the South Pacific, with lower-middle-income countries facing the lowest availability (59.1% public, 57.4% private) and significant affordability barriers. While upper-middle and high-income countries show better access, medicine prices remain high across the region. Urgent policy reforms and strategic initiatives are needed to address these ...
New Insights on the WHO-Listed Authority (WLA) Framework! The WHO has introduced an evidence-based, transparent framework to strengthen regulatory reliance and improve access to quality-assured medical products worldwide. The study highlights the WLA framework’s role in promoting regulatory standards across diverse regions, supporting the Sustainable Development Goals for global health. By enhancing collaboration between regulatory authorities, ...
Exciting news from the Global Pharma Health Fund! They’ve released a new low-cost Minilab test that detects toxic antifreeze agents like diethylene glycol and ethylene glycol in children’s cough syrups. This portable tool, especially crucial for regions lacking advanced labs, now includes protocols to safeguard against these harmful contaminants. Available for free in multiple languages, ...
Do you want to become a GSDP Auditor and help importers, wholesalers, and national supply agencies ensure product quality? QUAMED Learning presents the first-ever eLearning course for pharmaceutical professionals that focuses on developing skills needed by a GSDP auditor. The course is funded by the Bureau of Humanitarian Affairs of USAID and is ‘FREE’ for ...
The East African Community (EAC) has long faced challenges ensuring access to affordable, quality medicines. Since 2005, EAC Partner States have been working on an inter-country pooled procurement mechanism to address these issues, but progress has been slow. This study explores the evolution of this mechanism, highlighting two key stages: the initial promise stage, marked ...
The second day of the 2024 QUAMED General Assembly was opened by Joanna Darmanin from DG ECHO and Dirk Brems from DGD. We were happy to hear about their continuing commitment to equitable access to quality medicines. DGD has been instrumental in the conception and development of QUAMED as a network and as an association. ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.